The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNottingham University Hospitals NHS Trust

About this trial

The goal of this qualitative study is to explore the impact of antiviral treatment, or none, for chronic hepatitis B virus on the non-clinical (social) harms experienced by migrant populations living in the UK.

Two groups of participants living with hepatitis B virus will be interviewed, those taking the daily treatment, and those not prescribed any treatment.

Eligibility criteria

Qualifiers

Chronic HBsAg

Able to give informed consent in English

Able to converse in English

Any migrant population member (non-UK) including if born overseas or in the UK

Disqualifiers

Emotionally distressed due to HBV diagnosis

Current episode of decompensated cirrhosis

Current diagnosis of hepatocellular carcinoma

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

30 Participants
are grouped into 1 trial group

Locations

This trial has no locations